Pulse Biosciences publishes FIH data for nsPFA thyroid nodule treatment in Thyroid journal

PULSE BIOSCIENCES, INC.

Single-arm feasibility study by Prof. Spiezia at Ospedale del Mare, Naples, Italy; three cohorts.
Fully treated nodules (Cohort 3) showed up to 93% size reduction at 1 year (avg 86%), symptom relief as early as 2 weeks.
No intranodular fibrosis or scarring on follow-up ultrasounds.
nsPFA achieved 71% volume reduction in 1 month vs RFA's typical 6-month timeline for comparable shrinkage.
Publication in peer-reviewed journal Thyroid validates safety and effectiveness for benign nodules.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.